FNC
SLDB icon

First National Corp’s Solid Biosciences SLDB Stock Holding History

First National Corp’s Portfolio SLDB Stock Details SLDB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-67
Closed -$9K – 377
2019
Q1 		$9K Hold
67
– – ﹤0.01% 343
2018
Q4 		$27K Buy
+67
New +$31.5K 0.01% 258

Other funds holding SLDB

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

First National Corp's SLDB Position: Q2 2019 in Review

First National Corp sold out of Solid Biosciences (SLDB) in Q2 2019, closing a stake of 67 shares — an estimated $9K sold.

First National Corp first reported a position in SLDB in Q4 2018 and held it in 2 quarters. The position peaked at $27K in Q4 2018. 74 funds tracked by Wall St. Rank hold SLDB as of Q2 2019.

  • First National Corp reported no remaining Solid Biosciences position as of Q2 2019 after selling out during the quarter.
  • First National Corp sold 67 Solid Biosciences shares in Q2 2019, an estimated $9K.
  • First National Corp first reported a position in Solid Biosciences in Q4 2018 and held it in 2 quarters.
  • First National Corp's Solid Biosciences position peaked at $27K in Q4 2018.
  • 74 funds tracked by Wall St. Rank held Solid Biosciences as of Q2 2019.

Based on First National Corp's 13F filing for Q2 2019, filed 30 Jul 2019.